Pradaxa (Dabigatran)


Dangerous Blood Thinner

Pradaxa, known generically as dabigatran etexilate, is a blood thinner manufactured by the pharmaceutical giant Boehringer Ingelheim. It is used to prevent blood clots in patients who suffer from atrial fibrillation or other cardiac abnormalities. The medical community had been using another effective blood thinner, warfarin (also known under its brand name Coumadin), to treat patients since the 1950s.

Pradaxa injury case? Contact Devereaux, Stokes, Fernandez & Leonard today to schedule a free initial consultation.

In 2010, the FDA approved Pradaxa and Boehringer Ingelheim moved aggressively to market it to doctors and hospitals as an alternative to warfarin and Coumadin which had been safely used for over 60 years. In August of 2011, the company disclosed that its profits had increased and 60 percent of the increase in net sales in the first half of 2011 was due to its new drug Pradaxa. Boehringer spent over 464 million dollars in 2011 to market Pradaxa. This marketing was effective as in less than one year, 1.1 million prescriptions were written for this new drug Pradaxa. In 2011 Boehringer’s sales topped 1 billion dollars.

Link to Several Hundred Deaths

By late 2011, reports were coming in from hospitals all over the country that patients on this new drug Pradaxa were showing up in emergency rooms with uncontrolled bleeding. Unlike the previous blood thinner, warfarin, that had been safely used for over 60 years, there was no antidote. Tragically, all the doctors could do for some of these patients is stand by and watch them bleed to death. Eventually, the FDA called for a safety review in December of 2011. A November 2012 article in the New York Times ( discussed the alarming side effects of Pradaxa.

If you or a loved one is a victim of Pradaxa, it is time to seek justice. Our St. Louis Pradaxa attorneys litigating Pradaxa side effects lawsuits can advise you on how to determine whether you have a viable case. We can help you take legal action against a negligent health care provider or drug manufacturer. Did a doctor fail to screen you for drug interactions or notify you of risks to a fetus or your own health? Did the drug manufacturer fail to warn you through a black box warning or otherwise?

Contact Our Missouri Dabigatran Litigation Attorneys

Our St. Louis pharmaceutical litigation law firm has helped many people recover compensation after they were harmed by dangerous and defective drugs. Sometimes health care providers are held liable; sometimes product manufacturers are. In order to evaluate your case, we will thoroughly evaluate all known facts.

Devereaux, Stokes, Fernandez & Leonard welcomes the opportunity to provide valuable information. We offer free initial consultations with no further obligation. Founded in 1976, our firm combines the talents of four highly skilled trial lawyers, each of whom has received the highest possible AV® Preeminent™ 5.0 out of 5 rating* from Martindale-Hubbell. We handle cases throughout Missouri and Southern Illinois.

*AV Preeminent and BV Distinguished are certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedures, standards and policies. Martindale-Hubbell is the facilitator of a peer review rating process. Ratings reflect the confidential opinions of members of the Bar and the judiciary. Martindale-Hubbell ratings fall into two categories – legal ability and general ethical standards.

Contact us for a free consultation